Administration of GYY4137 slightly reduced MAP, preserved or restored the OTR, VEGF, and AVPR in the heart, suggesting cardioprotection as has been reported in myocardial I/R [43–46] and chronic heart failure [47]. This evidence concerns the gene OXTR and congestive heart failure.